243 related articles for article (PubMed ID: 33152099)
1. Measuring mineralised tissue formation and resorption in a human 3D osteoblast-osteoclast co-culture model.
Remmers S; Mayer D; Melke J; Ito K; Hofmann S
Eur Cell Mater; 2020 Nov; 40():189-202. PubMed ID: 33152099
[TBL] [Abstract][Full Text] [Related]
2. A 3D in vitro bone organ model using human progenitor cells.
Papadimitropoulos A; Scherberich A; Güven S; Theilgaard N; Crooijmans HJ; Santini F; Scheffler K; Zallone A; Martin I
Eur Cell Mater; 2011 May; 21():445-58; discussion 458. PubMed ID: 21604244
[TBL] [Abstract][Full Text] [Related]
3. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
4. Relevance of osteoclast-specific enzyme activities in cell-based in vitro resorption assays.
Bernhardt A; Koperski K; Schumacher M; Gelinsky M
Eur Cell Mater; 2017 Jan; 33():28-42. PubMed ID: 28098926
[TBL] [Abstract][Full Text] [Related]
5. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.
Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M
J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943
[TBL] [Abstract][Full Text] [Related]
6. 3D Environment Is Required In Vitro to Demonstrate Altered Bone Metabolism Characteristic for Type 2 Diabetics.
Häussling V; Aspera-Werz RH; Rinderknecht H; Springer F; Arnscheidt C; Menger MM; Histing T; Nussler AK; Ehnert S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805833
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.
Tani-Ishii N; Tsunoda A; Umemoto T
J Periodontal Res; 1997 Aug; 32(6):480-6. PubMed ID: 9379315
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
9. Biofabrication of a co-culture system in an osteoid-like hydrogel matrix.
Zehnder T; Boccaccini AR; Detsch R
Biofabrication; 2017 May; 9(2):025016. PubMed ID: 28266351
[TBL] [Abstract][Full Text] [Related]
10. Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectin.
Krumbholz G; Junker S; Meier FMP; Rickert M; Steinmeyer J; Rehart S; Lange U; Frommer KW; Schett G; Müller-Ladner U; Neumann E
Clin Exp Rheumatol; 2017; 35(3):406-414. PubMed ID: 28079506
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk of osteoblast and osteoclast precursors on mineralized collagen--towards an in vitro model for bone remodeling.
Bernhardt A; Thieme S; Domaschke H; Springer A; Rösen-Wolff A; Gelinsky M
J Biomed Mater Res A; 2010 Dec; 95(3):848-56. PubMed ID: 20824694
[TBL] [Abstract][Full Text] [Related]
12. Human bone-derived cells support formation of human osteoclasts from arthroplasty-derived cells in vitro.
Neale SD; Fujikawa Y; Sabokbar A; Gundle R; Murray DW; Graves SE; Howie DW; Athanasou NA
J Bone Joint Surg Br; 2000 Aug; 82(6):892-900. PubMed ID: 10990320
[TBL] [Abstract][Full Text] [Related]
13. The Role of miR-21 in Osteoblasts-Osteoclasts Coupling In Vitro.
Smieszek A; Marcinkowska K; Pielok A; Sikora M; Valihrach L; Marycz K
Cells; 2020 Feb; 9(2):. PubMed ID: 32093031
[TBL] [Abstract][Full Text] [Related]
14. Catabolic activity of osteoblast lineage cells contributes to osteoclastic bone resorption
Pirapaharan DC; Olesen JB; Andersen TL; Christensen SB; Kjærsgaard-Andersen P; Delaisse JM; Søe K
J Cell Sci; 2019 May; 132(10):. PubMed ID: 30975918
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro.
Mulari MT; Qu Q; Härkönen PL; Väänänen HK
Calcif Tissue Int; 2004 Sep; 75(3):253-61. PubMed ID: 15148559
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional characterization of osteoclast bone-resorbing activity in the resorption lacunae.
Soysa NS; Alles N; Aoki K; Ohya K
J Med Dent Sci; 2009 Sep; 56(3):107-12. PubMed ID: 20099473
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
18. Comparison of osteoclastogenesis and resorption activity of human osteoclasts on tissue culture polystyrene and on natural extracellular bone matrix in 2D and 3D.
Kleinhans C; Schmid FF; Schmid FV; Kluger PJ
J Biotechnol; 2015 Jul; 205():101-10. PubMed ID: 25562421
[TBL] [Abstract][Full Text] [Related]
19. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
20. Human osteoclast maturation from bone marrow cells co-cultured with osteoblast from ethmoid sinus.
Ishino T; Yajin K; Takeno S; Furukido K; Takumida M; Hirakawa K
Rhinology; 2003 Mar; 41(1):49-53. PubMed ID: 12677741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
